Results 81 to 90 of about 1,314,763 (265)

Perception and Satisfaction with Dental Appearance and its Association with Oral Health Related Quality of Life Among Students at Muhimbili University of Health and Allied Sciences, Tanzania [PDF]

, 2011
Dental esthetics has not been seen to be important in most developing countries and research in this regard is meager. Due to rapid increase in global network the effect of a pleasant appearance is now recognized to be very important, hence may lead to ...
Tumaini, Simon
core  

The independent contribution of neighborhood disadvantage and individual-level socioeconomic position to self-reported oral health: a multilevel analysis

, 2007
© Blackwell Munksgaard 2007ObjectivesTo examine the association between neighborhood disadvantage and individual-level socioeconomic position (SEP) and self-reported oral health.MethodsA population-based cross-sectional study conducted in 2003 among ...
Gary D. Slade, Anne E. Sanders, Sanders, Anne E., Spencer, A., Gavin Turrell, Marcenes, W., Marcenes, Wagner, A. John Spencer, Slade, G., Wagner Marcenes, Slade, Gary D., Spencer, A. John, Turrell, G., Sanders, A., Turrell, Gavin   +14 more
core   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan, Lei Zhou, Jingzi ZhangBao, Hongmei Tan, Zhouzhou Wang, Chao Quan   +5 more
wiley   +1 more source

Movement Disorders in Aicardi–Goutières Syndrome and Response to Immunomodulation

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT This study characterizes movement disorders and treatment responses in seven children with Aicardi–Goutières syndrome (AGS). We retrospectively evaluated motor phenotypes, neuroimaging, and interferon signatures in patients treated with baricitinib or anifrolumab. Spasticity affected all patients, while dystonia was present in 4/7.
Enrique Gonzalez Saez‐Diez, Monica Ferrer Socorro, Kathryn Yang, Nicole Battaglia, Zainab Zaman, Mariko Bennett, Adeline Vanderver, Pui Y. Lee, Lauren A. Henderson, Milena M. Andzelm, Darius Ebrahimi‐Fakhari   +10 more
wiley   +1 more source

Oral health improvement plan for Connecticut, 2013-2018.

, 2012
Previously issued: Oral health improvement plan for Connecticut, 2007-2012. Hartford : Connecticut Oral Health Initiative, [2007?].; Supported by the Centers for Disease Control and ...

core  

Oral health and dental care in Australia: key facts and figures trends 2014 [PDF]

, 2014
Highlights key trends in the oral health and dental care of the Australian population using the most recently available data. It is the latest in the Oral health and dental care in Australia: key facts and figures suite of printed publications and web ...

core  

Oral Health

Nursing Research and Practice, 2012
Terry Fulmer, Rita A. Jablonski, Elizabeth Mertz, Mary George, Stefanie Russell   +4 more
openaire   +3 more sources

Persistent Bilateral [18F]THK5351 and Migrating Unilateral [18F]FDG Uptake in Anti‐LGI1 Encephalitis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Anti–leucine‐rich glioma‐inactivated 1 encephalitis (LGI1‐E) can cause persistent cognitive deficits, but the mechanisms remain unclear. A 40‐year‐old woman with LGI1‐E presented with subacute cognitive deficits and showed mild left medial temporal lobe (MTL) swelling and fluid‐attenuated inversion recovery (FLAIR) hyperintensity on initial ...
Yusuke Akitomi, Kenichiro Taira, Masanori Kurihara, Kenji Ishibashi, Kenji Ishii, Fumio Suzuki, Aya Midori Tokumaru, Makoto Hara, Atsushi Iwata   +8 more
wiley   +1 more source

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source

ABC of oral health: Oral health and disease

BMJ, 2000
Holt, R, Roberts, G, Scully, C
openaire   +3 more sources